Cargando…
Circulating miRNAs in HER2-Positive and Triple Negative Breast Cancers: Potential Biomarkers and Therapeutic Targets
Breast cancer is one of the most prevalent diseases among women worldwide and is highly associated with cancer-related mortality. Of the four major molecular subtypes, HER2-positive and triple-negative breast cancer (TNBC) comprise more than 30% of all breast cancers. While the HER2-positive subtype...
Autores principales: | Gupta, Ishita, Rizeq, Balsam, Vranic, Semir, Moustafa, Ala-Eddin Al, Al Farsi, Halema |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7554858/ https://www.ncbi.nlm.nih.gov/pubmed/32942528 http://dx.doi.org/10.3390/ijms21186750 |
Ejemplares similares
-
Breast Cancer During Pregnancy: A Marked Propensity to Triple-Negative Phenotype
por: Allouch, Soumaya, et al.
Publicado: (2020) -
Gene Expression and miRNAs Profiling: Function and Regulation in Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer
por: Sareyeldin, Rasha M., et al.
Publicado: (2019) -
Novel Nitrogen-Based Chalcone Analogs Provoke Substantial Apoptosis in HER2-Positive Human Breast Cancer Cells via JNK and ERK1/ERK2 Signaling Pathways
por: Rizeq, Balsam, et al.
Publicado: (2021) -
Presence of high-risk HPVs, EBV, and MMTV in human triple-negative breast cancer
por: Gupta, Ishita, et al.
Publicado: (2021) -
SARS-CoV-2 Infection and Lung Cancer: Potential Therapeutic Modalities
por: Gupta, Ishita, et al.
Publicado: (2020)